However, several recent studies highlighted that PCSK9 can also have various additional effects that are independent of the LDLR, that provide more information on the involvement of PCSK9 in cancer, type 2 diabetes, obesity and several cardiovascular disorders [32,33,34]. Here, LDLR is linked to obesity due to melanocortin 4 receptor deficiency.